Provention Bio is a clinical stage biopharmaceutical company that develops and commercializes therapeutics to prevent immune-mediated diseases. Its product candidates include PRV-031 teplizumab and monoclonal antibodies for type one diabetes, PRV-3279 for lupus, PRV-101 for coxsackie virus B, and PRV-015 for gluten-free diet non-responding celiac disease. The company has collaborations with Amgen and Hangzhou Zhongmei Huadong Pharmaceutical. Provention Bio was founded in 2016 and is based in Red Bank, New Jersey.
Featured Jobs
Related Companies
Other Resources